# A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

> **NCT04612517** · EARLY_PHASE1 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ZP7570
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04612517
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612517, "A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04612517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*